Science & Research

Gender Studies in Product Development: Scientific Issues and Approaches

November 1995

Table of Contents


Charge to the Workshop

Historical Overview

  • Women of Childbearing Potential and Early Clinical Trials
  • Policy Changes: The 1993 FDA Gender Guideline and NIH Initiatives

Panel Discussions and Recommendations

  • Panel I: Pharmacokinetics and Pharmacodynamics
  • Panel II: Hormonal Influences
  • Panel III: Study Design and Analysis

Public Hearing

FDA Recommendations: Strategies for Assessing Gender Effects

In Summary


This executive summary is also available as a single HTML document

Page Last Updated: 02/16/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English